Cagrilinitide 10mg
$168.00
Now shipping: 99.55% purity | 12.16 mg
Cagrilintide, also known as AM833, is a peptide being developed by Novo Nordisk to help address obesity and type 2 diabetes. This peptide works by targeting amylin and calcitonin receptors to reduce appetite, and delay gastric emptying, and ultimately contributes to significant weight loss.
In some trials, it has been shown to stimulate greater weight loss when used in combination with another drug, semaglutide. This combo is marketed under the name CagrSema and is showing a lot of promise in treating conditions that are challenging to manage.
Please note that all products featured here are intended exclusively for research and development purposes. They are not designed for any form of human consumption. These products have not undergone evaluation by the U.S. Food and Drug Administration.
Guarantee Safe and Secure Payment Checkout
Cagrilinitide 10mg
$168.00
What is Cagrilintide Peptide?
Cagrilintide peptide is a synthetic amylin analogue engineered for metabolic research. It mimics the effects of the natural hormone amylin, which helps regulate appetite and energy balance. In research settings, Cagrilintide is studied for its ability to reduce food intake and support long-term weight loss outcomes.
This 10mg vial is intended for research use only and not for human consumption.
Cagrilintide Dosage for Research
Cagrilintide dosage in clinical research varies, but common protocols explore weekly dosing schedules due to its long half-life. It’s often researched alongside GLP-1 receptor agonists, like Tirzepatide, for compounded effects on weight management.
Note: Always consult primary literature and institutional protocols for precise dosing guidance.
Benefits of Cagrilintide (Observed in Research)
- Promotes satiety and reduces caloric intake
- Potential to enhance fat loss
- Long-acting formula for once-weekly dosing
- May help delay gastric emptying
- Works well in combination with Tirzepatide in dual-agent protocols
Cagrilintide vs Tirzepatide vs Retatrutide
- Cagrilintide vs Tirzepatide: While both support fat loss, Cagrilintide targets the amylin receptor, whereas Tirzepatide works on GLP-1 and GIP pathways. Combined, they may amplify metabolic outcomes.
Cagrilintide vs Retatrutide: Retatrutide acts on multiple incretin receptors. Cagrilintide is more targeted but may complement these broader-acting agents in layered research.
Product Specifications:
- Peptide Name: Cagrilintide
- Purity: ≥99%
- Appearance: White lyophilized powder
- Molecular Formula & Weight: Proprietary research formula
- Storage: Store at 2–8°C. Protect from light.
- Form: 10mg lyophilized peptide
- Use: For research purposes only
Why Buy Cagrilintide from Elite Edge Biotech?
- High-purity peptides ≥99% for reliable research outcomes
- Transparent testing and third-party verified
- Secure checkout and fast shipping
Trusted source for cagrilintide peptide for sale
FAQs
Q: What is Cagrilintide used for in research?
A: Cagrilintide is studied for its appetite-suppressing effects, fat-loss support, and synergy with incretin-based compounds like Tirzepatide.
Q: Can I combine Cagrilintide and Tirzepatide in research?
A: Yes, many studies investigate their combined effects on weight loss due to their complementary mechanisms.
Q: Is Cagrilintide approved by the FDA?
A: No. Cagrilintide is not FDA-approved and is sold strictly for research purposes only.
Q: Where can I buy Cagrilintide online?
A: Elite Edge Biotech offers high-purity cagrilintide peptide for sale for licensed laboratory use.
*Please note that all products featured here are intended exclusively for research and development purposes. They are not designed for any form of human consumption. These products have not undergone evaluation by the U.S. Food and Drug Administration.
Reviews
There are no reviews yet.